Not applicableStudy completedNCT04768387What this trial is testingThe Effect of AI-based Microbiome Diet on IBS-M SymptomsWho this might be right forIrritable Bowel Syndrome Mixed Gazi University 25
Not applicableStudy completedNCT00619125What this trial is testingProposal Evaluating Time-specific Relationships Between Variables of Pain, Stress, and Bloating in IBS Diarrhea and Constipation Symptoms Using a Palm PilotWho this might be right forIBS, Diarrhea PredominantIBS, Constipation PredominantIBS, Mixed Symptoms University of North Carolina, Chapel Hill 85
Testing effectiveness (Phase 2)Looking for participantsNCT05776914What this trial is testingFecal Microbiota Transplantation for IBSWho this might be right forIrritable Bowel SyndromeDiarrhea Madhusudan (Madhu) Grover, MBBS 43
Large-scale testing (Phase 3)Looking for participantsNCT07168434What this trial is testingSaccharomyces Boulardii CNCM I-745 in Irritable Bowel SyndromeWho this might be right forIBS (Irritable Bowel Syndrome)IBS-D (Diarrhea-predominant)IBS, Mixed Symptoms Biocodex 406
Post-approval studies (Phase 4)Study completedNCT00142987What this trial is testingEfficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBSWho this might be right forIBS-C and IBS With Mixed Bowel Habits Novartis 664
Not applicableStudy completedNCT05157061What this trial is testingGOS to Reduce Symptom Severity in IBSWho this might be right forIrritable Bowel SyndromeIrritable Bowel Syndrome - ConstipationIrritable Bowel Syndrome - Diarrhoea+1 more Clasado 153
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07519395What this trial is testingInvestigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)Who this might be right forIrritable Bowel Syndrome GlaxoSmithKline 420
Testing effectiveness (Phase 2)Study completedNCT03806127What this trial is testingStudy to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel SyndromeWho this might be right forIrritable Bowel Syndrome Urovant Sciences GmbH 222